The data shown below were collected from the profiles of 36 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
| Title |
Single induction dose of etomidate versus other induction agents for endotracheal intubation in critically ill patients
|
|---|---|
| Published in |
Cochrane database of systematic reviews, January 2015
|
| DOI | 10.1002/14651858.cd010225.pub2 |
| Pubmed ID | |
| Authors |
Eric A Bruder, Ian M Ball, Stacy Ridi, William Pickett, Corinne Hohl |
| Abstract |
The use of etomidate for emergency airway interventions in critically ill patients is very common. In one large registry trial, etomidate was the most commonly used agent for this indication. Etomidate is known to suppress adrenal gland function, but it remains unclear whether or not this adrenal gland dysfunction affects mortality. |
X Demographics
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 9 | 25% |
| United Kingdom | 3 | 8% |
| Turkey | 2 | 6% |
| Japan | 2 | 6% |
| France | 1 | 3% |
| Colombia | 1 | 3% |
| Senegal | 1 | 3% |
| Thailand | 1 | 3% |
| Costa Rica | 1 | 3% |
| Other | 5 | 14% |
| Unknown | 10 | 28% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 25 | 69% |
| Practitioners (doctors, other healthcare professionals) | 8 | 22% |
| Scientists | 2 | 6% |
| Science communicators (journalists, bloggers, editors) | 1 | 3% |
Mendeley readers
The data shown below were compiled from readership statistics for 359 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Brazil | 2 | <1% |
| Canada | 1 | <1% |
| United Kingdom | 1 | <1% |
| Unknown | 355 | 99% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 60 | 17% |
| Other | 35 | 10% |
| Student > Ph. D. Student | 29 | 8% |
| Student > Bachelor | 29 | 8% |
| Researcher | 24 | 7% |
| Other | 66 | 18% |
| Unknown | 116 | 32% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 140 | 39% |
| Nursing and Health Professions | 30 | 8% |
| Social Sciences | 13 | 4% |
| Psychology | 11 | 3% |
| Pharmacology, Toxicology and Pharmaceutical Science | 9 | 3% |
| Other | 31 | 9% |
| Unknown | 125 | 35% |
Attention Score in Context
This research output has an Altmetric Attention Score of 35. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 22 January 2023.
All research outputs
#1,213,866
of 26,522,299 outputs
Outputs from Cochrane database of systematic reviews
#2,323
of 13,240 outputs
Outputs of similar age
#15,136
of 362,985 outputs
Outputs of similar age from Cochrane database of systematic reviews
#48
of 280 outputs
Altmetric has tracked 26,522,299 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 95th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 13,240 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 35.0. This one has done well, scoring higher than 82% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 362,985 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 95% of its contemporaries.
We're also able to compare this research output to 280 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 82% of its contemporaries.